Evaluating stability of attenuated Sabin and two novel type 2 oral poliovirus vaccines in children

Novel oral poliovirus vaccine type 2 (nOPV2) is being developed to reduce the rare occurrence of disease and outbreaks associated with the genetic instability of the Sabin vaccine strains. Children aged 1 to 5 years were enrolled in two related clinical studies to assess safety, immunogenicity, shed...

Descripción completa

Detalles Bibliográficos
Autores principales: Wahid, Rahnuma, Mercer, Laina, Gast, Chris, De Leon, Tirza, Sáez-Llorens, Xavier, Fix, Alan, Macadam, Andrew, Stephens, Laura, Chumakov, Konstantin, Smits, Saskia L., Murreddu, Marta, Konopka-Anstadt, Jennifer L., Steven Oberste, M., Burns, Cara C., Andino, Raul, Bachtiar, Novilia Sjafri, Tritama, Erman, Bandyopadhyay, Ananda S., Aguirre, Gabriela, Rüttimann, Ricardo, Konz, John O.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8837630/
https://www.ncbi.nlm.nih.gov/pubmed/35149714
http://dx.doi.org/10.1038/s41541-022-00437-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8837630/
https://www.ncbi.nlm.nih.gov/pubmed/35149714
http://dx.doi.org/10.1038/s41541-022-00437-5

Ejemplares similares